Heinz Lubenau (*1965) is a Pharmacist whose work is focused on the field of Targeted Oral Immunotherapy Development. He is the Chief Operating Officer of the biotech VAXIMM since 2016, the company he co-founded in 2008. Heinz received his PhD from the Institute of Pharmacy, Johannes-Gutenberg-University, Mainz. From 1994 to 2002 Heinz held several important positions in Clinical Research at the pharmaceutical company Servier, moving from Junior Project Leader to Clinical Research Manager and Project Director of Internal Medicine. From 2003 to 2008 Heinz held the position of Global Project Manager Biosimilar and Head of Preclinical and Clinical Development at BioGenerix. Heinz is the owner of several patents and patent applications and has an impressive track record of marketed drugs.